JP2004269517A5 - - Google Patents

Download PDF

Info

Publication number
JP2004269517A5
JP2004269517A5 JP2004041914A JP2004041914A JP2004269517A5 JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5 JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004041914 A JP2004041914 A JP 2004041914A JP 2004269517 A5 JP2004269517 A5 JP 2004269517A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
pseudoephedrine
pharmaceutical composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004041914A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004269517A (ja
JP3987501B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004041914A priority Critical patent/JP3987501B2/ja
Priority claimed from JP2004041914A external-priority patent/JP3987501B2/ja
Publication of JP2004269517A publication Critical patent/JP2004269517A/ja
Publication of JP2004269517A5 publication Critical patent/JP2004269517A5/ja
Application granted granted Critical
Publication of JP3987501B2 publication Critical patent/JP3987501B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004041914A 2003-02-19 2004-02-18 医薬組成物 Expired - Lifetime JP3987501B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004041914A JP3987501B2 (ja) 2003-02-19 2004-02-18 医薬組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003040664 2003-02-19
JP2004041914A JP3987501B2 (ja) 2003-02-19 2004-02-18 医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006313255A Division JP2007039473A (ja) 2003-02-19 2006-11-20 医薬組成物

Publications (3)

Publication Number Publication Date
JP2004269517A JP2004269517A (ja) 2004-09-30
JP2004269517A5 true JP2004269517A5 (enExample) 2007-01-25
JP3987501B2 JP3987501B2 (ja) 2007-10-10

Family

ID=33134116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004041914A Expired - Lifetime JP3987501B2 (ja) 2003-02-19 2004-02-18 医薬組成物

Country Status (1)

Country Link
JP (1) JP3987501B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
JP5896806B2 (ja) * 2012-03-28 2016-03-30 ロート製薬株式会社 内服組成物
CN102641367B (zh) * 2012-05-19 2014-02-26 陈亚徽 通光散清咽止咳糖及冲剂
JP6616968B2 (ja) * 2014-06-25 2019-12-04 興和株式会社 医薬組成物
CN104623586A (zh) * 2014-12-25 2015-05-20 陆莎 一种治疗咳嗽的中药混合物

Similar Documents

Publication Publication Date Title
TWI480272B (zh) 藉由5,6-二氫-1h-吡啶-2-酮與一或多種其他抗病毒化合物的組合物抑制c型肝炎病毒的方法
JP2005524658A5 (enExample)
JP2007529532A5 (enExample)
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
JP2007522094A5 (enExample)
JP2005538121A5 (ja) 多重遅延放出抗ウイルス物質産物、その使用法と製剤
JP2012502037A5 (enExample)
JP2008523153A5 (enExample)
SE0104341D0 (sv) New use
JP2007514005A5 (enExample)
JP2002509074A5 (enExample)
Rosini et al. The bivalent ligand approach as a tool for improving the in vitro anti‐Alzheimer multitarget profile of dimebon
JP2008110970A5 (enExample)
JP2007515426A5 (enExample)
JP2007523135A5 (enExample)
JP2009517411A5 (enExample)
JP2006515299A5 (enExample)
JP2005522432A5 (enExample)
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
JP2009518415A5 (enExample)
HUP0401805A2 (hu) Pulmonális betegségek kezelésére szolgáló vegyületek
JP2004269517A5 (enExample)
JP2009515927A5 (enExample)
WO2005118579A3 (en) Thiazole derivatives as chemokine receptor antagonists
WO2007087344A3 (en) Anti-histamine compositions and use thereof